Pro-apoptotic mechanisms of action of a novel vitamin E analog (α-TEA) and a naturally occurring form of vitamin E (δ-Tocotrienol) in MDA-MB-435 human breast cancer cells

Nutrition and Cancer

Volumn 48, Issue 1, 2004, Pages 95-105

  Shun, Ming Chieh ^a   Yu, Weiping ^a   Gapor, Abdul ^c   Parsons, Rachel ^b   Atkinson, Jeffrey ^b   Sanders, Bob G ^a   Kline, Kimberly ^a  

^a UNIVERSITY OF TEXAS AT AUSTIN   (United States)

^b BROCK UNIVERSITY   (Canada)

^c MALAYSIAN PALM OIL BOARD   (Malaysia)

Author keywords

[No Author keywords available]

Indexed keywords

2,5,7,8 TETRAMETHYL 2 (4,8,12 TRIMETHYLTRIDECYL)CHROMAN 6 YLOXYACETIC ACID; ALPHA TOCOPHEROL DERIVATIVE; DELTA TOCOTRIENOL; ESTROGEN; FAS ANTIGEN; STRESS ACTIVATED PROTEIN KINASE; TRANSFORMING GROWTH FACTOR BETA; TRANSFORMING GROWTH FACTOR BETA RECEPTOR; UNCLASSIFIED DRUG;

ANTINEOPLASTIC ACTIVITY; APOPTOSIS; ARTICLE; BREAST CANCER; BREAST EPITHELIUM; CANCER CELL CULTURE; CELL IMMORTALIZATION; CELL STRAIN MCF 7; CELL STRAIN MDA MB 435; CONCENTRATION RESPONSE; CONTROLLED STUDY; ENZYME ACTIVATION; EPITHELIUM CELL; GENE EXPRESSION; HUMAN; HUMAN CELL; TIME; UPREGULATION;

MINK CELL FOCUS-FORMING VIRUS;

EID: 3042551365     PISSN: 01635581     EISSN: None     Source Type: Journal    
DOI: 10.1207/s15327914nc4801_13     Document Type: Article

References (55)

1. Kamal-Eldin A and Appelqvist L-A: The chemistry and antioxidant properties of tocopherols and tocotrienols. Lipids 31, 671-701, 1996.
2. Prasad KN and Edwards-Prasad J: Effects of tocopherol (vitamin E) acid succinate on morphological alterations and growth inhibition in melanoma cells in culture. Cancer Res 42, 550-554, 1982.
3. Prasad KN and Edwards-Prasad J: Vitamin E and cancer prevention: recent advances and future potentials. J Am Coll Nutr 11, 487-500, 1992.
4. Schwartz J and Sklar G: The selective cytotoxic effects of carotenoids and α-tocopherol on human cancer cell lines in vitro. J Oral Maxillofac Surg 50, 367-373, 1992.
5. Turley JM, Sanders BG, and Kline K: RRR-α-tocopheryl succinate modulation of human promyelocytic leukemia (HL-60) cell proliferation and differentiation. Nutr Cancer 18, 201-213, 1992.
6. Charpentier A, Groves S, Simmons-Menchaca M, Turley J, Zhao B, et al.: RRR-α-tocopheryl succinate inhibits proliferation and enhances secretion of transforming growth factor-beta (TGF-β) by human breast cancer cells. Nutr Cancer 19, 225-239, 1993.
7. Fariss MW, Fortuna MB, Everett CK, Smith JD, Trent DF, et al.: The selective antiproliferative effects of α-tocopheryl hemisuccinate and cholesteryl hemisuccinate on murine leukemia cells result from the action of the intact compounds. Cancer Res 54, 3346-3351, 1994.
8. Nesaretnam K, Guthrie N, Chambers AF, and Carroll KK: Effect of tocotrienols on the growth of a human breast cancer cell line in culture. Lipids 30, 1139-1143, 1995.
9. Guthrie N, Gapor A, Chambers AF, and Carroll KK: Palm oil tocotrienols and plant flavonoids act synergistically with each other and with tamoxifen in inhibiting proliferation and growth of estrogen receptor-negative MDA-MB-435 and -positive MCF-7 human breast cancer cells in culture. Asia Pacific J Clin Nutr 6, 41-45, 1997.
10. Djuric Z, Heilbrun LK, Lababidi S, Everett-Bauer CK, and Fariss MW: Growth inhibition of MCF-7 and MCF-10A human breast cells by α-tocopheryl hemisuccinate, cholesteryl hemisuccinate and their ether analogs. Cancer Lett 111, 133-139, 1997.
11. He L, Mo H, Hadisusilo S, Qureshi AA, and Elson CE: Isoprenoids suppress the growth of murine B16 melanomas in vitro and in vivo. J Nutr 127, 668-674, 1997.
12. Guthrie N, Gapor A, Chambers AF, and Carroll KK: Inhibition of proliferation of estrogen receptor-negative MDA-MB-435 and -positive MCF-7 human breast cancer cells by palm oil tocotrienols and tamoxifen, alone and in combination. J Nutr 127, 544S-548S, 1997.
13. Nesaretnam K, Stephen R, Dils R, and Darbre P: Tocotrienols inhibit the growth of human breast cancer cells irrespective of estrogen receptor status. Lipids 33, 461-469, 1998.
14. Yu W, Simmons-Menchaca M, Gapor A, Sanders BG, and Kline K: Induction of apoptosis in human breast cancer cells by tocopherols and tocotrienols. Nutr Cancer 33, 26-32, 1999.
15. McIntyre BS, Briski KP, Gapor A, and Sylvester PW: Antiproliferative and apoptotic effects of tocopherols and tocotrienols on preneoplastic and neoplastic mouse mammary epithelial cells. Proc Soc Exp Biol Med 224, 292-301, 2000.
16. Neuzil J, Weber T, Gellert N, and Weber C: Selective cancer cell killing by α-tocopheryl succinate. Br J Cancer 84, 87-89, 2000.
17. Kline K, Yu W, and Sanders BG: Vitamin E: mechanisms of action as tumor cell growth inhibitors. J Nutr 131, 161S-163S, 2001.
18. Neuzil J, Weber T, Schroder A, Lu M, Ostermann G, et al.: Induction of cancer cell apoptosis by α-tocopheryl succinate: molecular pathways and structural requirements. FASEB J 15, 403-415, 2001.
19. Neuzil J, Weber T, Terman A, Weber C, and Brunk UT: Vitamin E analogues as inducers of apoptosis: implications for their potential anti-neoplastic role. Redox Rep 6, 143-151, 2001.
20. Yu W, Sanders BG, and Kline K: RRR-α-tocopheryl succinate inhibits EL4 thymic lymphoma cell growth by inducing apoptosis and DNA synthesis arrest. Nutr Cancer 27, 92-101, 1997.
21. Malafa MP and Neitzel LT: Vitamin E succinate promotes breast cancer tumor dormancy. J Surg Res 93, 163-170, 2000.
22. Barnett KT, Fokum FD, and Malafa MP: Vitamin E succinate inhibits colon cancer liver metastases. J Surg Res 106, 292-298, 2002.
23. Malafa MP, Fokum FD, Mowlavi A, Abusief M, and King M: Vitamin E inhibits melanoma growth in mice. Surgery 131, 85-91, 2002.
24. Malafa MP, Fokum FD, Smith L, and Louis A: Inhibition of angiogenesis and promotion of melanoma dormancy by vitamin E succinate. Ann Surg Oncol 9, 1023-1032, 2002.
25. Weber T, Lu M, Andera L, Lahm H, Gellert N, et al.: Vitamin E succinate is a potent novel antineoplastic agent with high selectivity and cooperativity with tumor necrosis factor-related apoptosis-inducing ligand (Apo2 ligand) in vivo. Clin Cancer Res 8, 863-869, 2002.
26. Wu K, Shan YJ, Zhao Y, Yu JW, and Liu BH: Inhibitory effects of RRR-alpha-tocopheryl succinate on benzo(a)pyrene (B(a)P)-induced forestomach carcinogenesis in female mice. World J Gastroenterol 7, 60-65, 2001.
27. Turley JM, Ruscetti FW, Kim S-J, Fu T, Gou FV, et al.: Vitamin E succinate inhibits proliferation of BT-20 human breast cancer cells: increased binding of cyclin A negatively regulates E2F transactivation activity. Cancer Res 57, 2668-2675, 1997.
28. You H, Yu W, Sanders BG, and Kline K: RRR-α-tocopheryl succinate induces MDA-MB-435 and MCF-7 human breast cancer cells to undergo differentiation. Cell Growth Differ 12, 471-480, 2001.
29. You H, Yu W, Munoz-Medellin D, Brown PH, Sanders BG, et al.: Role of extracellular signal -regulated kinase pathway in RRR-α-tocopheryl succinate-induced differentiation of human MDA-MB-435 breast cancer cells. Mol Carcinogenesis 33, 228-236, 2002.
30. Yu W, Sanders BG, and Kline K: RRR-α-tocopheryl succinate induction of DNA synthesis arrest of human MDA-MB-435 cells involves TGF-β- independent activation of p21 Waf1/Cip1. Nutr Cancer 43, 227-236, 2002.
31. Yu W, Sanders BG, and Kline K: RRR-α-tocopheryl succinate-induced apoptosis of human breast cancer cells involves Bax translocation to mitochondria. Cancer Res 63, 2483-2491, 2003.
32. Neuzil J, Svensson I, Weber T, Weber C, and Brunk UT: α-Tocopheryl succinate-induced apoptosis in Jurkat T cells involves caspase-3 activation, and both lysosomal and mitochondrial destabilisation. FEBS Lett 445, 295-300, 1999.
33. Neuzil J, Zhao M, Ostermann G, Sticha M, Gellert N, et al.: α-Tocopheryl succinate, an agent with in vivo anti-tumour activity, induces apoptosis by causing lysosomal instability. Biochem J 362, 709-715, 2002.
34. Weber T, Dalen H, Andera L, Negre-Salvayre A, Auge N, et al.: Mitochondria play a central role in apoptosis induced by α-tocopheryl succinate, an agent with antineoplastic activity: comparison with receptor-mediated pro-apoptotic signaling. Biochemisty 42, 4277-4291, 2003.
35. Elson CE: Suppression of mevalonate pathway activities by dietary isoprenoids: protective roles in cancer and cardiovascular disease. J Nutr 125, 1666S-1672S, 1995.
36. Serbinova E, Kagan V, Han D, and Packer L: Free radical recycling and intramembrane mobility in the antioxidant properties of α-tocopherol and α-tocotrienol. Free Radic Biol Med 10, 263-275, 1991.
37. Guthrie N, Gapor A, Chambers AF, and Carroll KK: Inhibition of protein kinase C in MDA-MB-435 human breast cancer cells by palm oil tocotrienols. Proc Can Fed Biol Soc 39, Abstract 262, 1996.
38. Theriault A, Chao J-T, Wang Q, Gapor A, and Adeli K: Tocotrienol: a review of its therapeutic potential. Clin Biochem 32, 309-319, 1999.
39. Komiyama K, Iizuka K, Yamaoka M, Watanabe H, Tsuchiya N, et al.: Studies on the biological activity of tocotrienols. Chem Pharm Bull 37, 1369-1371, 1989.
40. Gould MN, Haag JD, Kennan WS, Tanner MA, and Elson CE: A comparison of tocopherol and tocotrienol for the chemoprevention of chemically induced rat mammary tumors. Am J Clin Nutr 53, 1068S-1070S, 1991.
41. Elson CE and Yu SG: The chemoprevention of cancer by mevalonate-derived constituents of fruits and vegetables. J Nutr 124, 607-614, 1994.
42. Lawson KA, Anderson K, Menchaca M, Atkinson J, Sun L-Z, et al.: Novel vitamin E analogue decreases syngeneic mouse mammary tumor burden and reduces lung metastasis. Mol Cancer Ther 2, 437-444, 2003.
43. Gapor A, Leong WL, Ong ASH, Kawada T, Watanabe H, et al.: Production of high concentration tocopherols and tocotrienols from palm oil by-products. US Patent No. 5,190,618, March 2, 1993.
44. Price JE, Polyzos A, Zhang RD, and Daniel LM: Tumorigenicity and metastasis of human breast carcinoma cell lines in nude mice. Cancer Res 50, 717-721, 1990.
45. Klotz DM, Castles CG, Fuqua SAW, Spriggs LL, and Hill SM: Differential expression of wildtype and variant ER mRNAs by stocks of MCF-7 breast cancer cells may account for differences in estrogen responsiveness. Biochem Biophys Res Commun 210, 609-615, 1995.
46. Soule HD, Maloney TM, Wolman SR, Peterson WD, Brenz R, et al.: Isolation and characterization of a spontaneously immortalized human breast epithelial cell line, MCF-10. Cancer Res 50, 6075-6086, 1990.
47. Yu W, Israel K, Liao QY, Aldaz CM, Sanders BG, et al.: Vitamin E succinate (VES) induces Fas sensitivity in human breast cancer cells: role for Mr 43,000 Fas in VES-triggered apoptosis. Cancer Res 59, 953-961, 1999.
48. Raingeaud J, Gupta S, Rogers JS, Dickens M, Han J, et al.: Pro-inflammatory cytokines and environmental stress cause p38 mitogen-activated protein kinase activation by dual phosphorylation on tyrosine and threonine. J Biol Chem 270, 7420-7426, 1995.
49. Yu W, Liao QY, Hantash FM, Sanders BG, and Kline K: Activation of extracellular signal-regulated kinase and c-Jun-NH2-terminal kinase but not p38 mitogen-activated protein kinases is required for RRR-α-tocopheryl succinate-induced apoptosis of human breast cancer cells. Cancer Res 61, 6569-6576, 2001.
50. Yu W, Heim K, Qian M, Simmons-Menchaca M, Sanders BG, et al.: Evidence for role of transforming growth factor-β in RRR-α-tocopheryl succinate-induced apoptosis of human MDA-MB-435 breast cancer cells. Nutr Cancer 27, 267-278, 1997.
51. Zhao B, Yu W, Qian M, Simmons-Menchaca M, Brown P, et al.: Involvement of activator protein-1 (AP-1) in induction of apoptosis by vitamin E succinate in human breast cancer cells. Mol Carcinog 19, 180-190, 1997.
52. Turley JM, Fu T, Ruscetti FW, Mikovits JA, Bertolette DC, et al.: Vitamin E succinate induces Fas-mediated apoptosis in estrogen receptor-negative human breast cancer cells. Cancer Res 57, 881-890, 1997.
53. Yu W, Simmons-Menchaca M, You H, Brown P, Birrer MJ, et al.: RRR-α-tocopheryl succinate induction of prolonged activation of c-jun amino-terminal kinase and c-jun during induction of apoptosis in human MDA-MB-435 breast cancer cells. Mol Carcinog 22, 247-257, 1998.
54. Charpentier A, Simmons-Menchaca M, Yu W, Zhao B, Qian M, et al.: RRR-α-tocopheryl succinate enhances TGF-β1, -β2, and -β3 and TGF-β R-II expression by human MDA-MB-435 breast cancer cells. Nutr Cancer 26, 237-250, 1996.
55. Machlin LJ: Vitamin E. In: Handbook of Vitamins, LJ Machlin (ed). New York: Marcel Dekker, 1984, pp 99-145.